Fury, M. G., Baxi, S., Shen, R., Kelly, K. W., Lipson, B. L., Carlson, D., . . . Pfister, D. G. (2011). Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Chicago ZitierstilFury, Matthew G., Shrujal Baxi, Ronglai Shen, Katherine W. Kelly, Brynna L. Lipson, Diane Carlson, Hilda Stambuk, Sofia Haque, und David G. Pfister. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.
MLA ZitierstilFury, Matthew G., et al. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.